Ушбу ишга иқтибос қилган ишлар

3 та иш

Иш: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

1. The evolution of cellular-based immunotherapy in the treatment of gastric cancer: an overview of clinical trials

   Lang Wu, Jasur Rizaev, Khaled Fahmi Fawy +7

   МақолаCAR-T cell therapy researchClinical & Translational Oncology20261 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.000259

2. Septin oligomerization regulates persistent expression of ErbB2/HER2 in gastric cancer cells

   Elizabeth A. Marcus, Elmíra Tokhtaeva, Shahlo Тurdikulova +6

   МақолаFungal and yeast genetics researchBiochemical Journal20160 иқтибос

   ABIABI:AkademIndex/openalex/2016.article.000063

3. Challenges and Suggestions in the Management of Stomach and Colorectal Cancer in Uzbekistan: The Third Report of the Uzbekistan–Korea Oncology Consortium

   Chai Hong Rim, Won Jae Lee, Odiljon Akhmedov +5

   Шарҳ мақолаGastric Cancer Management and OutcomesInternational Journal of Environmental Research and Public Health20230 иқтибос

   ABIABI:AkademIndex/openalex/2023.review-article.000114